Topiramate augmentation in treatment-resistant obsessive–compulsive disorder: a retrospective, open-label case series
Author:
Publisher
Wiley
Subject
Psychiatry and Mental health,Clinical Psychology
Reference28 articles.
1. Open-Label Topiramate as Primary or Adjunctive Therapy in Chronic Civilian Posttraumatic Stress Disorder
2. Topiramate Titration and Tolerability
3. Sequential administration of augmentation strategies in treatment-resistant obsessive-compulsive disorder
4. Augmentation of Serotonin Reuptake Inhibitors in Refractory Obsessive-Compulsive Disorder Using Adjunctive Olanzapine
5. Gabapentin Augmentation for Fluoxetine-Treated Patients With Obsessive-Compulsive Disorder
Cited by 92 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmakotherapie;S3-Leitlinie Zwangsstörungen;2024
2. Factors related to the severity of obsessive–compulsive symptoms and their impact on suicide risk in epileptic patients;Epilepsy & Behavior;2023-09
3. L‐theanine combination therapy with fluvoxamine in moderate‐to‐severe obsessive–compulsive disorder: A placebo‐controlled, double‐blind, randomized trial;Psychiatry and Clinical Neurosciences;2023-05-27
4. Treatment-resistant OCD: Pharmacotherapies in adults;Comprehensive Psychiatry;2023-01
5. Specialty knowledge and competency standards for pharmacotherapy for adult obsessive-compulsive disorder;Psychiatry Research;2021-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3